Our client,ONCOPEPTIDES AB (PUBL),is a biotech company focused on research, development, and commercialization of therapies for difficult-to-treat hematological diseases.
The company uses itsproprietary Peptide Drug Candidate platform (PDC)to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells.
Pepaxti (melphalan flufenamide, also called melflufen) has been granted Marketing Authorization, in the European Union, the EEA-countries Iceland, Lichtenstein and Norway, as well as in the UK.
Pepaxti is indicated in combination with dexamethasone for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-CD38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy.
For patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation.
Oncopeptides is developing several new compounds based on its proprietary technology platforms and is listed on the Small Cap segment on Nasdaq Stockholm with the ticker ONCO.
Oncopeptides' headquarter and laboratory are located in Stockholm, Sweden.
Today the company consists of around 80 co-workers in total with a growing European organization.
Discover more about Oncopeptides at (cliccare sul bottone "Candidati ora").
For the new Italian affiliate, we are looking for aKey Account Manager North of Italy(Lombardia)
Position:
TheKey Account Manager (KAM)reports to the Commercial Director (CD) and is responsible for contributing to the national and area sales objectives for Oncopeptides' commercial products, while meeting or exceeding territory level goals.
This role will require building and developing a network of business relationships with therapeutic specialists and key account stakeholders for the commercialization of melphalan flufenamide.
The KAM will ensure the customer and patient needs are being met through effective engagement of prescribers coupled with a focus on account management, consistently demonstrating value.
The KAM will also be responsible for achieving performance objectives in a highly competitive market.
The KAM will be accountable for all aspects of territory performance including execution of our brand strategy and engaging internal resources to address the needs of our customers, patients, and caregivers.
Essential Duties and Responsibilities: Deliver onthe assignedarea and territorysales goalsby aligning with Oncopeptides' brand strategy & vision Identification ofmarket trends and opportunitiesWork with the CD to developtactical strategiesto support account needsUnderstandthe policies and dynamics of clinic/hospital leadership,procurement, and contracting and engage internal resources as appropriate.Familiarity with tender process.Achieve/Exceed Sales goalsfor your region and/or territoryOwn the relationship with hematology account stakeholdersEngage withkey accountsand account leaders, compliantly tailoring the brand strategy to influence value drivers within each accountWork collaboratively with Commercial Director and cross-functional teammates (i.e.
Medical, Market Access) to identifypartnership opportunitiesExpertise in clinical data, disease state, and account managementEffectivelyanalyzes data and market trendsto help build strategic business plans to address challenges and capitalize on opportunitiesActively engage in our culture of continuous learning and developmentThe Key Account Manager will contribute to the development of:CRM databaseBusiness plansNational and regional KOL listsImplementing our organizationaloperating modelwithin the territoryMSc Degree (Laurea Magistrale) in biology or pharmacy or equivalent5 Years in the Pharmaceutical/ MarketplacePrevious experience in pharmaceutical/biotech sales as part of a high performing onco-hematology team in a competitive environmentHematology experience is required, multiple myeloma experience preferredAbility to thrive in a startup environment by maintaining a solutions-oriented mindset, embracing change and taking ownership of customer facing initiativesPrior launch(es) of onco-hematology drug(s), preferably in a competitive marketSolid understanding of the business of hematology, patient pathways, market access, etc.Knowledge of hematology practices, hospitals, academic medical centers,Active Network of hematologists (heads of department and specialists in myeloma), hospital pharmacists and key decision makers in the uptake of the drug at hospital or regional level.Support and contribute to the market access operation in the assigned regions and hospitals: identify key stakeholders and the key decision makers and process necessary for the uptake of the Drug in the hospitals.
Teamwork with MSL, and external RAM to facilitate the regional and hospital uptake of the drug where necessary under the coordination of the Commercial DirectorUnderstanding of multiple distribution models, including Specialty Distribution and distribution of H-band drugsSolid analytical, organizational, problem-solving, and communication skillsAbility to develop strong relationships with both internal and external customersProven track record of developing and maintaining a network of health care professionals within aligned accountsDemonstrated commitment to acting with integrity in a highly regulated business environment
#J-18808-Ljbffr